Bcworldpharm Co (XKRX:200780) Cyclically Adjusted Revenue per Share: ₩7,219.76 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:200780 Bcworldpharm Co Ltd XKRX:200780
66 GF Score
Price ₩3,045.00
GF Value ₩5,479.32
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bcworldpharm Co Cyclically Adjusted Revenue per Share?

Bcworldpharm Co XKRX:200780 +0.16% 66 Cyclically Adjusted Revenue per Share is ₩7,219.76 as of Jun. 2026. GuruFocus rates XKRX:200780 with a GF Score™ of 66/100 and a GF Value™ of ₩5,479.32 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bcworldpharm Co's adjusted revenue per share for the three months ended in Jun. 2026 was ₩2,051.325. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩7,219.76 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bcworldpharm Co's average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-15), Bcworldpharm Co's current stock price is ₩3045.00. Bcworldpharm Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₩7,219.76. Bcworldpharm Co's Cyclically Adjusted PS Ratio of today is 0.42.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bcworldpharm Co was 0.92. The lowest was 0.42. And the median was 0.67.


Bcworldpharm Co  (XKRX:200780) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bcworldpharm Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3045.00/7219.76
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bcworldpharm Co was 0.92. The lowest was 0.42. And the median was 0.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bcworldpharm Co Cyclically Adjusted Revenue per Share Related Terms


Bcworldpharm Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bcworldpharm Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bcworldpharm Co Cyclically Adjusted Revenue per Share Chart

Bcworldpharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 6,165.60 6,458.13 6,932.89

Bcworldpharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,618.94 6,720.35 6,932.89 7,073.55 7,219.76

XKRX:200780 vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Cyclically Adjusted PS Ratio falls into.


XKRX:200780
66GF Score
Bcworldpharm Co Ltd XKRX:200780
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bcworldpharm Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bcworldpharm Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2051.325/126.4904*126.4904
=2,051.325

Current CPI (Jun. 2026) = 126.4904.

Bcworldpharm Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1,006.945 101.461 1,255.346
201612 1,189.355 101.561 1,481.292
201703 1,177.563 102.851 1,448.221
201706 1,082.613 102.611 1,334.552
201709 1,156.135 103.491 1,413.076
201712 1,829.022 102.991 2,246.353
201803 1,252.681 104.101 1,522.103
201806 1,466.238 104.130 1,781.086
201809 1,425.183 105.651 1,706.305
201812 1,273.884 104.351 1,544.159
201903 1,167.142 104.491 1,412.872
201906 1,130.972 104.881 1,363.996
201909 1,181.400 105.200 1,420.488
201912 1,773.789 105.121 2,134.366
202003 1,478.829 105.354 1,775.512
202006 1,422.874 105.112 1,712.271
202009 1,342.771 106.198 1,599.355
202012 1,340.276 105.765 1,602.907
202103 1,411.454 107.357 1,663.003
202106 1,493.305 107.579 1,755.821
202109 1,501.688 108.759 1,746.511
202112 1,624.237 109.676 1,873.242
202203 1,555.031 111.848 1,758.605
202206 1,802.666 114.072 1,998.907
202209 1,726.309 114.715 1,903.508
202212 1,946.719 115.179 2,137.897
202303 1,906.232 116.507 2,069.569
202306 1,830.599 117.182 1,976.012
202309 1,666.144 118.964 1,771.561
202312 1,917.858 118.837 2,041.371
202403 1,600.053 120.123 1,684.865
202406 1,731.947 120.007 1,825.511
202409 1,566.589 120.861 1,639.554
202412 3,015.461 121.135 3,148.770
202503 1,407.450 122.590 1,452.230
202506 1,818.076 122.611 1,875.598
202509 1,882.949 123.402 1,930.079
202512 3,115.779 123.939 3,179.913
202603 1,940.017 125.236 1,959.449
202606 2,051.325 126.490 2,051.325

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₩7,219.76 mean?
Bcworldpharm Co (XKRX:200780) has a Cyclically Adjusted Revenue per Share of ₩7,219.76 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bcworldpharm Co and its competitors.
Is Bcworldpharm Co's Cyclically Adjusted Revenue per Share too high?
Bcworldpharm Co's current Cyclically Adjusted Revenue per Share is ₩7,219.76. Overall, Bcworldpharm Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bcworldpharm Co's Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Bcworldpharm Co's Cyclically Adjusted Revenue per Share of ₩7,219.76 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bcworldpharm Co and its competitors. Bcworldpharm Co's current Cyclically Adjusted Revenue per Share is ₩7,219.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bcworldpharm Co stock overvalued right now?
Based on GuruFocus' analysis, Bcworldpharm Co (XKRX:200780) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,479.32, compared to a current price of ₩3,045.00 — trading 44.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₩7,219.76. Bcworldpharm Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bcworldpharm Co (XKRX:200780), the current Cyclically Adjusted Revenue per Share is ₩7,219.76 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bcworldpharm Co (XKRX:200780) Overvalued in 2026?

Based on GuruFocus' analysis, Bcworldpharm Co stock appears to be undervalued. The current stock price of ₩3,045.00 is trading 44.4% below its estimated GF Value™ of ₩5,479.32. GuruFocus considers Bcworldpharm Co to be Possible Value Trap.

Key valuation signals for XKRX:200780:

  • Cyclically Adjusted Revenue per Share: ₩7,219.76
  • GF Value™: ₩5,479.32 vs. price of ₩3,045.00 (44.4% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the XKRX:200780 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bcworldpharm Co Business Description

Address 872-23 Yeoju-nam-ro, Ganam-eup, Gyeonggi-do, Yeoju-si, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
66GF Score

Get the complete analysis for XKRX:200780

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩3,045.00
Price
₩5,479.32
GF Value